title: Prostaglandin B(2) delivers a co-stimulatory signal leading to T cell activation.
abstract: Most of the data accumulated to date on the immunoregulatory effects of prostaglandins (PG) on T cell activation stem from the archetypal inhibitory effect of PGE(2). In this study we provide instead, the first evidence that exogenous PGB(2), a catabolic metabolite of PGE(2), synergizes with signals delivered by T cell receptor (TCR) engagement to induce interleukin-2 (IL-2) production and IL-2 receptor (IL-2R) alpha-expression in Jurkat cells. Accordingly, PGB(2) enhances the proliferation of anti-CD3-activated peripheral blood lymphocytes (PBL). In terms of cellular signaling, we present evidence that PGB(2) activates tyrosine kinase activities and efficiently increases c-fos mRNA expression and nuclear factor-kappa B (NF-kappa B) translocation to the nucleus. Owing to these features, PGB(2) appears as a new lipid mediator capable of delivering an ancillary signal leading to T lymphocyte activation.
authors.affiliation: INSERM U. 364, IFR50, Faculté de Médecine Pasteur, avenue de Valombrose, 06107 Nice Cedex 02, France.
authors.forename: N
authors.initials: N
authors.lastname: Cattan
authors.forename: D
authors.initials: D
authors.lastname: Mary
authors.forename: A
authors.initials: A
authors.lastname: Peleraux
authors.forename: B
authors.initials: B
authors.lastname: Mari
authors.forename: C
authors.initials: C
authors.lastname: Aussel
authors.forename: B
authors.initials: B
authors.lastname: Rossi
mesh_terms: D015703:Antigens, CD / Q000378:metabolism; D000945:Antigens, Differentiation, T-Lymphocyte / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D004789:Enzyme Activation / Q000187:drug effects; D016762:Genes, fos / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000096:biosynthesis / Q000235:genetics; D019169:Jurkat Cells; D037181:Lectins, C-Type; D008213:Lymphocyte Activation / Q000187:drug effects*; D016328:NF-kappa B / Q000378:metabolism; D011456:Prostaglandins B / Q000494:pharmacology*; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D011948:Receptors, Antigen, T-Cell / Q000187:drug effects / Q000378:metabolism; D015375:Receptors, Interleukin-2 / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000166:cytology / Q000187:drug effects* / Q000276:immunology*; D000099192:CD69 Antigens
chemical_list: D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D007376:Interleukin-2; D037181:Lectins, C-Type; D016328:NF-kappa B; D011456:Prostaglandins B; D011505:Protein-Tyrosine Kinases; D012333:RNA, Messenger; D011948:Receptors, Antigen, T-Cell; D015375:Receptors, Interleukin-2; D000099192:CD69 Antigens; C042026:prostaglandin B2